Bausch & Lomb (BLCO) Operating Income (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Operating Income came in at $83.0 million in Q2 2026, up 854.55% on a YoY basis from $8.7 million in Q2 2025, and up 151.52% quarter-over-quarter from $33.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Operating Income (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Operating Income for 6 consecutive years, with $83.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Income rose 854.55% year-over-year to $83.0 million; the trailing twelve-month figure through Jun 2026 stood at $323.0 million (up 797.22% YoY), and the FY2025 full-year result was $113.0 million, down 30.25% from the prior year.
- Operating Income advanced to $83.0 million in Q2 2026 per BLCO's latest filing, from $33.0 million in the prior quarter.
- Across five years, Operating Income topped out at $112.0 million in Q4 2025 and bottomed at -$83.0 million in Q1 2025.
- Historically, Operating Income has averaged $40.4 million across 5 years, with a median of $44.5 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Operating Income sank 1483.33% in 2025, then jumped 854.55% in 2026.
- Over 5 years, Operating Income stood at $51.0 million in 2022, then decreased by 3.92% to $49.0 million in 2023, then surged by 77.55% to $87.0 million in 2024, then climbed by 28.74% to $112.0 million in 2025, then decreased by 25.89% to $83.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $83.0 million, $33.0 million, and $112.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 83.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.00 Mn |
| Mar 31, 2026 | 33.00 Mn |
| Dec 31, 2025 | 112.00 Mn |
| Sep 30, 2025 | 95.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | -83.00 Mn |
| Dec 31, 2024 | 87.00 Mn |
| Sep 30, 2024 | 43.00 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 49.00 Mn |
| Sep 30, 2023 | 40.00 Mn |
| Jun 30, 2023 | 43.00 Mn |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 51.00 Mn |
| Sep 30, 2022 | 46.00 Mn |
| Jun 30, 2022 | 56.00 Mn |
| Mar 31, 2022 | 54.00 Mn |
| Dec 31, 2021 | 92.00 Mn |
| Sep 30, 2021 | 94.00 Mn |